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ABSTRAK
Penyakit ‘sickle cell’ ketika mengandung bukanlah satu perkara biasa di Malaysia. 
Kami membentangkan satu kes berkenaan penyakit ‘sickle cell’ ketika mengandung 
dengan beberapa komplikasi ibu dan bayi. Pesakit kami telah mengalami sakit 
badan secara tiba-tiba dan pemecahan darah pada trimester yang ketiga. Walaupun 
ubat pencegah darah beku telah diberikan, pesakit tersebut telah mendapat 
darah beku pada kaki. Kandungan itu juga telah mengalami masalah seperti 
darah tinggi yang bahaya dan pembesaran bayi dalam kandungan yang terbantut 
sehingga memerlukan pembedahan untuk melahirkan bayi. Bayi berkenaan telah 
dimasukkan ke unit rawatan rapi bayi kerana pra-matang dan kurang berat badan 
ketika lahir. Pendekatan dari pelbagai disiplin dalam merawat pesakit ‘sickle cell’ 
ini sangat penting bagi mendapatkan proses kehamilan yang lebih baik. 
Kata kunci: anemia, sickle cell, kandungan kehamilan
ABSTRACT
Sickle cell disease (SCD) in pregnancy is uncommon in Malaysia. We present a 
case of sickle cell disease in pregnancy with maternal and fetal complications. The 
patient presented with acute pain crisis and hemolysis in the third trimester. Despite 
thromboprophylaxis, she developed deep vein thrombosis. The pregnancy was 
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further complicated by severe pre-eclampsia and intrauterine growth restriction 
which require preterm caesarean section. The baby was admitted to Neonatal 
Intensive Care Unit due to prematurity and low birth weight. Multidisciplinary 
approach in managing pregnant patient with SCD is essential in achieving good 
obstetrics outcome. 
Keywords: anemia, sickle cell disease, pregnancy outcomes
wks of gestation. She did not receive 
any pre-pregnancy counselling as she 
had defaulted previous haematology 
follow up. Her hemoglobin (Hb) at 
booking was 8.6 g/dL.
 Her first pregnancy was complicated 
by acute pain crisis and hemolysis. 
She delivered a low birth weight baby 
(2.05kg) at 37 wks via emergency 
caesarean section due to fetal distress.
  She was diagnosed with sickle cell 
disease at the age of eight. Severe 
veno-occlusion resulted in auto 
amputation of her right fingers and 
toes. She had recurrent acute pain 
crisis and multiple blood transfusions 
since childhood. She underwent a 
cataract surgery at the age of 14. Her 
younger brother was also diagnosed 
with SCD. Her husband and first born 
were both screened negative for the 
disease. 
 On assessment, she appeared pale 
and dehydrated with blood pressure 
of 120/60 mmHg and pulse rate of 94 
beats/minute. Abdominal examination 
revealed symphysio-fundal height 
of 31 cm which was appropriate for 
gestation. There was no evidence of 
calf swelling or tenderness. Hb was 
7.7 g/dL and ultrasound assessment 
showed a singleton fetus with growth 
parameters plotted at 10th centile and 
INTRODUCTION
Sickle cell disease (SCD) is an 
autosomal recessive disorder, in which 
abnormal haemoglobin is formed due 
to mutation in the β-globin gene. In 
low oxygen condition, polymerisation 
of this abnormal haemoglobin results 
in fragile sickled erythrocytes. The 
mechanically weak red blood cells 
break down easily, causing capillary 
blockage. As a result, patients with 
SCD often present with haemolysis 
and acute pain crisis. Pregnancy in 
women with SCD has been associated 
with higher rate of maternal and 
fetal complications including pre-
eclampsia, preterm birth, fetal growth 
restriction and stillbirth (Villers et al. 
2008). In this case report, we discuss 
the complications and management 
of pregnant woman with sickle cell 
disease.
CASE REPORT
The 32-year-old woman, of Odisha 
origin, Gravida 2 Para 1, a known case 
of sickle cell disease, presented to us 
at 31-wks gestation with generalised 
body ache and diarrhoea. She was 
a late booker and her first antenatal 
assessment was only performed at 26 
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estimated fetal weight of 1697 g.
 Diagnosis of acute pain crisis 
secondary to dehydration was made. 
She was treated in a high dependency 
ward, with nasal oxygen, intravenous 
fluid and parenteral morphine. She 
also developed acute haemolytic 
episode which was evident by low Hb 
(6.7g/dL), raised lactate dehydrogenase 
level (1139 U/l) and reticulocytes 
counts (14.8%). She was subsequently 
transfused with two units of packed red 
cell. Unfortunately, despite receiving 
low molecular weight heparin 
(LMWH) as thromboprophylaxis, she 
developed deep vein thrombosis in 
her left leg. 
 One week later, she developed pre-
eclampsia with elevated blood pressure 
of 158/95 mmHg and significant 
proteinuria (urine protein creatinine 
ratio was 0.574 g/mmol). Thus she 
was given oral nifedipine for blood 
pressure stabilization before delivery. 
Intramuscular dexamethasone 
was administered to promote fetal 
lung maturity. Patient underwent 
emergency Caesarean section at 33 
week of gestation and delivered a 
baby boy with birthweight of 1690 g 
and Apgar score of 5 at 1 minute and 
8 at 5 minutes of life. The baby was 
admitted to the Neonatal Intensive 
Care Unit (NICU) due to prematurity 
and low birth weight. 
 Anti-hypertensive drug was 
discontinued post-delivery as 
her blood pressure subsequently 
normalised. Therapeutic dose of 
LMWH was continued for three 
months postpartum. Patient had opted 
for intramuscular Depo Provera as 
contraception and is currently under 
active follow up by the haematology 
team.
DISCUSSION
Sickle cell disease (SCD) is common 
amongst individuals of African, Greek, 
India, Turkish and Middle Eastern 
descent (Centers for Disease Control 
and Prevention 2017).  This condition 
is rare in Malaysia with only a few 
cases observed particularly in Indian 
patients of Odisha origin. Odisha is 
one of the 29 states in India with high 
prevalence of SCD (Balgir 2007). 
 The number of pregnant women 
with SCD is increasing despite its 
higher risk of maternal and fetal 
morbidities. In a latest retrospective 
cohort study, women with SCD were 
found to have higher odds for severe 
preeclampsia (odds ratio, 3.75; 95% 
confidence interval, 2.21-6.38), 
preterm delivery (odds ratio, 2.50; 
95% confidence interval, 1.93-3.21), 
small for gestational age (odds ratio, 
1.96; 95% confidence interval, 1.18-
3.25), and caesarean delivery (odds 
ratio, 1.93; 95% confidence interval, 
1.40-2.67) (Kuo & Caughey 2016).
 Women with SCD should be 
counselled regarding the maternal and 
fetal risks in pregnancy. It is imperative 
that these women receive thorough 
examination during antenatal 
booking, blood pressure and urinalysis 
monitoring, and serial fetal growth 
scan for early detection of pregnancy 
complications (Royal College of 
Obstetricians and Gynecologists 
2011). Low dose aspirin should be 
commenced as early as 12 weeks 
in these women as pre-eclampsia 
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prophylaxis. Unfortunately, our patient 
was not prescribed aspirin due to her 
late booking. 
 Physiological changes in pregnancy 
may precipitate sickle cell crisis. 
Avoidance of the precipitating factors 
such as excessive vomiting or stress 
should be emphasized during pre-
conception counselling and antenatal 
booking. Opioids is the treatment 
of choice in pregnancy for acute 
painful crisis whilst non-steroidal 
anti-inflammatory drugs (NSAIDS) are 
contraindicated during the first and 
third trimester due to an increased risk 
of miscarriage and premature closure 
of fetal ductus arteriosus (Canadian 
Haemoglobinopathy Association 
2014). Our patient was well managed 
with intravenous morphine during her 
acute pain crisis. 
 The previous case report in 1984, 
resulted in spontaneous vaginal 
delivery of a normally grown fetus 
at term (Rachagan et al. 1984). In 
contrast, our patient developed severe 
preeclampsia at 33 weeks which 
warranted a preterm delivery via 
caesarean section. 
 Some studies have shown an 
increased risk of pre-eclampsia, 
placenta abruption, peripartum 
cardiomyopathy and acute sickle 
cell crisis in near term pregnancy. 
Thus, delivery for normal growing 
fetus should be aimed at 38 weeks to 
prevent late pregnancy and perinatal 
complications (Villers et al. 2008). 
 Despite thrombo-prophylaxis, 
our woman developed deep vein 
thrombosis. This could be contributed 
by multiple factors including reduced 
mobility, increased blood viscosity 
by the pregnancy and dehydration, 
as well as endothelial dysfunction 
which was worsened by her sickled 
erythrocytes.
 Routine prophylaxis transfusion 
is not recommended unless the 
pregnancy is complicated by recurrent 
acute pain crisis, acute chest syndrome 
and symptomatic anemia (Canadian 
Haemoglobinopathy Association 
2014; Davis et al. 2017). The decision 
for blood transfusion should be made 
judiciously, taking into account the risks 
involved such as alloimmunisation, 
transfusion reaction and transmission 
of infection.
 Pre-pregnancy counselling plays 
an important role in preventing 
pregnancy complications for women 
with SCD. Contraception counselling 
is equally important in preventing 
unplanned pregnancy in women with 
uncontrolled disease. An intrauterine 
copper device (IUCD) is efficient 
for long term contraception while 
progesterone-only contraception is 
safe in sickle cell disease (Canadian 
Haemoglobinopathy Association 
2014).
CONCLUSION
While pregnancy carries significant 
risks to a woman with sickle cell anemia 
and her fetus, a favorable outcome is 
possible with a holistic approach by a 
multidisciplinary team. Adequate pre-
conception counselling, avoidance of 
sickle cell crisis precipitants, regular 
antenatal visits with serial growth 
scans, thrombo-prophlaxis with 
LMWH and prompt treatment of acute 
events will improve the outcome of 
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the pregnancy of a woman with SCD. 
Contraception is important and should 
be discussed with every woman with 
SCD.
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